Literature DB >> 28092694

Proton pump inhibitors: Risks of long-term use.

Leonardo Henry Eusebi1,2, Stefano Rabitti1, Maria Laura Artesiani1, Dania Gelli1, Marco Montagnani1, Rocco Maurizio Zagari1, Franco Bazzoli1.   

Abstract

Proton pump inhibitors are among the most commonly prescribed classes of drugs, and their use is increasing, in particular for long-term treatment, often being over-prescribed and used for inappropriate conditions. In recent years, considerable attention has been directed towards a wide range of adverse effects, and even when a potential underlying biological mechanism is plausible, the clinical evidence of the adverse effect is often weak. Several long-term side effects have been investigated ranging from interaction with other drugs, increased risk of infection, reduced intestinal absorption of vitamins and minerals, and more recently kidney damage and dementia. The most recent literature regarding these adverse effects and their association with long-term proton pump inhibitor treatment is reviewed, and the mechanisms through which these possible complications might develop are discussed.
© 2017 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  complications; long-term risk; proton pump inhibitor

Mesh:

Substances:

Year:  2017        PMID: 28092694     DOI: 10.1111/jgh.13737

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  38 in total

1.  Only full adherence to proton pump inhibitors protects against drug-induced upper gastrointestinal bleeding.

Authors:  Borja Ruiz; Urko Aguirre; Ana Estany-Gestal; Luca Rodella; Pablo Ruiz; Adolfo Figueiras; Alfonso Carvajal; Luisa Ibáñez; Anita Conforti; Marian M de Pancorbo; Xavier Vidal; Luis H Martin; Carmelo Aguirre
Journal:  Eur J Clin Pharmacol       Date:  2018-07-24       Impact factor: 2.953

2.  Acid-gastric antisecretory effect of the ethanolic extract from Arctium lappa L. root: role of H+, K+-ATPase, Ca2+ influx and the cholinergic pathway.

Authors:  Luisa Mota da Silva; Ligia de Moura Burci; Sandra Crestani; Priscila de Souza; Rita de Cássia Melo Vilhena de Andrade Fonseca da Silva; Nessana Dartora; Lauro Mera de Souza; Thales Ricardo Cipriani; José Eduardo da Silva-Santos; Eunice André; Maria Fernanda de Paula Werner
Journal:  Inflammopharmacology       Date:  2017-07-28       Impact factor: 4.473

Review 3.  Gastrinomas: Medical or Surgical Treatment.

Authors:  Jeffrey A Norton; Deshka S Foster; Tetsuhide Ito; Robert T Jensen
Journal:  Endocrinol Metab Clin North Am       Date:  2018-09       Impact factor: 4.741

4.  A dual intervention in geriatric patients to prevent drug-related problems and improve discharge management.

Authors:  Johanna Freyer; Lysann Kasprick; Ralf Sultzer; Susanne Schiek; Thilo Bertsche
Journal:  Int J Clin Pharm       Date:  2018-07-26

5.  Association of Proton Pump Inhibitors With Hospitalization Risk in Children With Oropharyngeal Dysphagia.

Authors:  Daniel R Duncan; Paul D Mitchell; Kara Larson; Maireade E McSweeney; Rachel L Rosen
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-12-01       Impact factor: 6.223

6.  Commonly Prescribed and Over-the-Counter Drugs as Secondary Causes of Osteoporosis-Part Two.

Authors:  Joseph Pizzorno; Lara Pizzorno
Journal:  Integr Med (Encinitas)       Date:  2021-06

7.  LAPAROSCOPIC ANTIREFLUX SURGERY: ARE OLD QUESTIONS ANSWERED? SHOULD IT BE USED CONJOINED WITH ENDOSCOPIC THERAPY FOR BARRETT'S ESOPHAGUS?

Authors:  Shiwei Han; Donald E Low
Journal:  Arq Bras Cir Dig       Date:  2022-06-24

Review 8.  Proton Pump Inhibitors: Are They a Real Threat to the Patient?

Authors:  Sofia Xavier; Joana Magalhães; José Cotter
Journal:  GE Port J Gastroenterol       Date:  2018-02-28

9.  The need of a multicomponent guiding approach to personalize clopidogrel treatment.

Authors:  Conti Valeria; Sellitto Carmine; Manzo Valentina; Iannaccone Teresa; Costantino Maria; Torsiello Martina; Accarino Giancarlo; Nicolella Giovanna; Corbi Graziamaria; Filippelli Amelia
Journal:  Pharmacogenomics J       Date:  2020-10-09       Impact factor: 3.550

10.  Evaluation of mutagenesis, necrosis and apoptosis induced by omeprazole in stomach cells of patients with gastritis.

Authors:  Ana Maria Oliveira Ferreira da Mata; Marcia Fernanda Correia Jardim Paz; Ag-Anne Pereira Melo de Menezes; Antonielly Campinho Dos Reis; Bruna da Silva Souza; Carlos Dimas de Carvalho Sousa; Sônia Alves Machado; Thiago Soares Gondim Medeiros; Chandan Sarkar; Muhammad Torequl Islam; Javad Sharifi-Rad; Sevgi Durna Daştan; Mohammed M Alshehri; João Marcelo de Castro E Sousa; Ana Amélia de Carvalho Melo Cavalcante
Journal:  Cancer Cell Int       Date:  2022-04-18       Impact factor: 6.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.